| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new paradigm is needed for financing the pandemic fund
|
Reid-Henry, Simon
|
|
|
400 |
10349 |
p. 345-346
|
artikel
|
| 2 |
Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
|
Mehta, Puja
|
|
|
400 |
10349 |
p. 338-339
|
artikel
|
| 3 |
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
|
|
|
|
400 |
10349 |
p. 359-368
|
artikel
|
| 4 |
Bronchiolitis
|
Dalziel, Stuart R
|
|
|
400 |
10349 |
p. 392-406
|
artikel
|
| 5 |
Calvarium indentations in multiple myeloma and CAR T-cell therapy
|
Munoz, Javier
|
|
|
400 |
10349 |
p. 391
|
artikel
|
| 6 |
Cathie Sudlow: devoted to data
|
Watts, Geoff
|
|
|
400 |
10349 |
p. 351
|
artikel
|
| 7 |
Department of Error
|
|
|
|
400 |
10349 |
p. 358
|
artikel
|
| 8 |
Department of Error
|
|
|
|
400 |
10349 |
p. 358
|
artikel
|
| 9 |
Department of Error
|
|
|
|
400 |
10349 |
p. 358
|
artikel
|
| 10 |
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
|
Kim, Byeong-Keuk
|
|
|
400 |
10349 |
p. 380-390
|
artikel
|
| 11 |
Lowering LDL cholesterol in clinical practice: time for change?
|
Abushamat, Layla A
|
|
|
400 |
10349 |
p. 341-343
|
artikel
|
| 12 |
Lower taxes or greater health equity
|
Marmot, Michael
|
|
|
400 |
10349 |
p. 352-353
|
artikel
|
| 13 |
Monkeypox: a global wake-up call
|
The Lancet,
|
|
|
400 |
10349 |
p. 337
|
artikel
|
| 14 |
Monkeypox PHEIC decision hoped to spur the world to act
|
Zarocostas, John
|
|
|
400 |
10349 |
p. 347
|
artikel
|
| 15 |
New Dutch regulations to alleviate drug shortages
|
Biedermann, Ferry
|
|
|
400 |
10349 |
p. 349-350
|
artikel
|
| 16 |
Perilous two-tier COVID-19 global vaccine roll-out
|
Durrheim, David N
|
|
|
400 |
10349 |
p. 355-356
|
artikel
|
| 17 |
Reforms to accelerated approval of new medicines: long overdue
|
Hwang, Thomas J
|
|
|
400 |
10349 |
p. 357-358
|
artikel
|
| 18 |
SOS Brazil: democracy under attack
|
Hallal, Pedro C
|
|
|
400 |
10349 |
p. 355
|
artikel
|
| 19 |
The Health and Care Act 2022: challenges and priorities for embedding research in the NHS
|
Toh, Cheng Hock
|
|
|
400 |
10349 |
p. 343-345
|
artikel
|
| 20 |
Tobacco company funding and conflict of interest
|
Pattemore, Philip
|
|
|
400 |
10349 |
p. 356
|
artikel
|
| 21 |
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis
|
Liew, Jean W
|
|
|
400 |
10349 |
p. 340-341
|
artikel
|
| 22 |
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Deodhar, Atul
|
|
|
400 |
10349 |
p. 369-379
|
artikel
|
| 23 |
Urgent need to update NICE guidelines on imaging for transient ischaemic attack
|
MacSweeney, Shane
|
|
|
400 |
10349 |
p. 357
|
artikel
|
| 24 |
Urvashi Vaid
|
Green, Andrew
|
|
|
400 |
10349 |
p. 354
|
artikel
|
| 25 |
Violence against health workers rises during COVID-19
|
Thornton, Jacqui
|
|
|
400 |
10349 |
p. 348
|
artikel
|
Tijdschrift beschrijving